AMTM vs BMY · rev $14.39B vs P/E 17, rev $24.46B
Amentum Holdings Inc. (AMTM) versus Bristol-Myers Squibb Company (BMY) — a side-by-side from cached financials, not a winner call.
Amentum Holdings Inc. (AMTM) is a specialty business services company listed on US.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Latest reported AMTM revenue for 2025-10-03 was $14.39B. Net income was $66.0M. Revenue was up 71.6% from 2024-09-27 to 2025-10-03. AMTM currently screens at market cap $4.87B.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
AMTM currently screens at market cap $4.87B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Not investment advice. Open the AMTM and BMY stock pages for the full models.
Not investment advice.